Results
Alembic Pharmaceuticals FY26 Revenue Rises 10% to ₹7,345 Crore
Alembic Pharmaceuticals reported FY26 revenue growth of 10% to ₹7,345 crore with net profit increasing 16% to ₹675 crore, driven by strong performance in international generics and strategic acquisiti
